In vitro evaluation of no carrier added, carrier added and cross-complexed [90Y]-EDTMP provides evidence for a novel “foreign carrier theory”

This publication has 10 references indexed in Scilit:

• Binding studies of [18F]-fluoride and polyphosphonates radiolabelled with [99mTc], [111In], [153Sm] and [188Re] on bone compartments: Verification of the pre vivo model?
  Bone, 2005
• Binding studies of [18F]-fluoride and polyphosphonates radiolabelled with [111In], [99mTc], [153Sm], and [188Re] on bone compartments: a new model for the pre vivo evaluation of bone seekers?
  Bone, 2004
• Labelling of EDTMP (Multibone®) with [111In], [99mTc] and [188Re] using different carriers for “cross complexation”
  Applied Radiation and Isotopes, 2004
• Bone lesion detection with carrier-added 99mTc-EDTMP in comparison with 99mTc-DPD
  Nuclear Medicine Communications, 2004
• Transfer standard for beta decay radionuclides in radiotherapy
  Applied Radiation and Isotopes, 2004
• Removal of the surface layers of human cortical bone allografts restores in vitro osteoclast function reduced by processing and frozen storage
  Bone, 2003
• Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists
  Radiotherapy and Oncology, 2000
• Studies of the Structure and Composition of Rhenium−1,1-Hydroxyethylidenediphosphonate (HEDP) Analogues of the Radiotherapeutic Agent ¹⁸⁶ReHEDP
  Inorganic Chemistry, 1997
• Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• Simultaneous study of the biodistribution of radio-yttrium complexed with EDTMP and citrate ligands in tumour-bearing rats
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992